Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
Latest reported MGX revenue for 2025-12-31 was $25.2M. Net income was -$87.9M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. MGX currently screens at market cap $44.4M.
Use this MGX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MGX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MGX SEC filings page. Lician reads the product cache first so this HTML stays unique to Metagenomi, Inc. Common Stock even when a live quote feed is slow.
Latest cached year on this hub. Full MGX income, balance, and cash tables.